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ABSTRACT
Background:Trigeminal neuralgia (TN) is a debilitating condition
characterized by sudden, usually unilateral, severe, brief, stabbing recurrent
episodes of pain in the distribution of one or more branches of the trigeminal
nerve. The treatment of refractory trigeminal neuralgia is often a challenge in
clinical practice. Nowadays, radiofrequency (RF) is one of the most effective
options for treatment. this study aims to compare the effectiveness of
percutaneous fluoroscopic-guided Thermocoagulation radiofrequency (TRF)
versus pulsed radiofrequency (PRF) for management of patients with refractory
trigeminal neuralgia.
Patients and methods :A randomized comparative study was carried out in
Zagazig university hospitals. Overall, 90 adult patients suffering from
refractory TN were randomly assigned to two groups (45 in each). The
TRFgroup was treated with TRF and the PRF group was treated with PRF.
Results :There were significant improvements in both groups as regards Visual
Analog Score which was higher in the TRF group at 12 months of follow‑up
after that, pain began to return in the PRF group rather than in the TRF group.
Conclusion: Both thermocoagulation radiofrequency and pulsed
radiofrequency are effective in relieving pain associated with trigeminal
neuralgia. Excellent pain relief and reduced consumption of analgesics for
more than 12 months were observed in patients who received
thermocoagulation radiofrequency compared with pulsed radiofrequency
treatment of refractory trigeminal neuralgia.
Keywords: Thermocoagulation, pulsed, radiofrequency, refractory, trigeminal
neuralgia

INTRODUCTION
N is a debilitating condition characterized
by agonizing, paroxysmal shooting,
lancinating and often like an electric shock. It
can be triggered by light touch in any area
innervated by trigeminal nerve[1].
It has been recently shown that TN is the most
frequent type of facial pain and that, among
facial pain syndromes, the overall incidence of
TN ranging from 12.6 to 28.9 per 100.00
patient / years[2].

T
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It was demonstrate that a bidirectional
relationship between poor sleep and pain, and
craniofacial pain and sleep disturbance in a
reciprocal manner and it is essential for
clinicians to consider both aspects of
treatment.. Other studies reported that patients
with TN were found to have a 2.17 times
greater risk of developing a sleep
disorder[3][4][5].
Psychometric scores indicated mild to
moderate depression, moderate to severe
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anxiety, and moderate to severe functional
limitation of daily life activities in TN
patients[6][7].
The guidelines on TN management that have
been agreed upon and jointly published by the
American Academy of Neurology (AAN) and
the European Federation of Neurological
Societies (EFNS) were very clear as to the
medical treatment as first line of treatment. If
the patient reaches the therapeutic dosage
without achieving the desired pain relief so
interventional
procedures
should
be
proposed[8].
Hence, the definition of ‘refractory trigeminal
neuralgia’ is easy: a patient with TN that is a
non-responder to either of medical treatment
or a patient that cannot take them because of
specific counter indications or who cannot
reach the therapeutic dosage because of
excessive adverse effects[9].
By far, one of the most common procedures to
treat pain is the use of radiofrequency (RF)
lesioning. The main advantages of RF seem to
be its effectiveness and high pain relief rate
without the dangerous complications of surgical
procedures and lack of secondary effects and
reduction of oral medication[10].
Thermocoagulation RF (TRF) is the most
common technique for treating refractory TN.
It involves high-temperature effects of highfrequency current on the gasserian ganglia. The
underlying mechanism was due to damaging
the nerve’s pain signal transmission by high
temperature, as well as nonmyelinated fibers
that conduct epicritic stimuli and block the
transmission of electric activity [11].
Pulsed radiofrequency (PRF) treatment is
defined as the delivery of short pulses of
radiofrequency via a needle tip, which does not
result in an actual thermal lesion. There are
mixed views regarding the use of PRF for
trigeminal neuralgia (TN) [12].
Aim of the work: To compare the
effectiveness of percutaneous fluoroscopicguided Thermocoagulation radiofrequency
(TRF) versus pulsed radiofrequency (PRF) for
management of patients with refractory
trigeminal neuralgia.
Abdalla M., et al
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PATIENTS AND METHODS
This study was conducted in zagazig
University Hospitals, from January 2015 to
March 2018, The work has been carried out in
accordance World Medical Association
(Declaration of Helsinki) for studies involving
humans before prospective collection of
patient’s data and after informed consent was
obtained from patients.
Inclusion criteria
Ninety five subjects presenting with refractory
facial neuralgia at Zagazig university hospitals,
of either sex, average age 48 - 70 years old,
undergo a multidisciplinary assessment,
including complete neurological evaluation and
magnetic resonance imaging (MRI)
Patients with refusal to procedure, local
infection at the needle puncture, uncooperative
patients and patients with coagulopathy were
excluded from the study.
Sampling :
All patients who met the inclusion and
exclusion criteria were included. 90 patients
were included during the study period of
3 years (duration of the study). Patients were
selected from among those presenting to the
pain clinic at Zagazig university hospitals.
Patients were randomly assigned to one of the
two treatment groups (45 patients in each
group). Patients in the TRF group were treated
with TRF, whereas patients in the PRF group
were treated with PRF.
All participants were subjected to the
following:
 Pre-interventional evaluation:
 History of personal data, onset, course, duration
and severity of pain.
 Concurrent medical illnesses.
 Investigations: Coagulation profile, MRI and
fundoscopy to exclude papilledema or disc
bulge due to intracranial lesions
 Clinical examination: general, local and
neurological
 Baseline evaluative scale for pain: visual
analogue scale assessment (VAS).
Procedure:
In the operating theater, standard monitors
(ECG, noninvasive blood pressure monitoring
258 | P a g e
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and pulse oximetry) were connected to the
patient and O2 was administered via a nasal
prong. The patient was placed in the supine
position with slight hyperextension of the neck
to facilitate the submental view by fluoroscopy.
Conscious sedation was complemented by use
of 1 μg/kg fentanyl and 0.05mg/kg midazolam,
after 5 min and 2 min; respectively, before local
anesthesia infiltration at the site of puncture,
and by 0.75 mg/kg propofol, shots during the
needle journey through foramen ovale and
during RF periods. After proper sterilization of
the skin and draping, Fluoroscopy was adjusted
in the submental view (caudocranial by 30°–
50°) with slight obliqueness (10°–30°) to
visualize the foramen oval at the inner side of
the mandibular ramus of the affected side. The
site of needle entry was 2–3 cm lateral to the
angle of the mouth. The RF needle
(Neurotherm,100 mm, 22 gauge, 5 mm active
tip, curved) was inserted after injection of
lidocaine 1 % infiltration. The tunnel view
technique for the needle path was tried, aiming
at the pupil in anterior view and the midzigoma in lateral view. The needle passed endon until a depth of 5–7 cm. Once the needle
enters the foramen ovale into Meckel’s cavity,
the C-arm is then rotated laterally to ascertain
the depth of penetration. The final position of
the needle tip is just past the angle formed by
the petrosal ridge of the temporal bone and the
clivus. (Fig. 1) The propofol sedation is
discontinued, the patient is allowed to awaken,
and Trial stimulation: Firsts, sensory
stimulation is carried out at 50 Hz. The
definitive position of the electrode was verified
by inducing paresthesia with sensory
stimulation between 0.1–0.3 V in the affected
painful area. As a second step, motor
stimulation was performed using 2 Hz with
0.1–1 Volt, and the masseter muscle
contractions were observed.
After sensory and motor stimulation, RF
therapy was started by use of the RF generator
(Neurotherm 1100) as:
In TRF group: RF lessoning was done at 60 ◦C
for 60 s; 5 ◦C increments for 60 seconds up
until we reach a maximum of 70 ◦C for 60
Abdalla M., et al
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seconds; at each stage, the patient was allowed
to recover from the I.V propofol, and we tested
for reduction of response to pinprick
stimulation.
In PRF group:PRF current is applied for 6
minutes at 45 V, with a pulse width of 10 ms
and a pulse frequency of 4 Hz. The cut-off
needle tip temperature was set at 42 °C.
All patients were transferred to the recovery
room, vital signs were monitored, and ice packs
were applied to the patients’ faces to reduce
facial ecchymosis. Age, sex, VAS and
consumption of analgesics (pre-procedure and
post-procedure) at 1st
day, 1st week 1st
month, , 3th month, 6th month and 12th
months were recorded as a part of our routine
clinic follow-up. Less than 50 % improvement
in VAS was regarded as unsatisfactory block;
50–80 % improvement of VAS was regarded as
satisfactory block; more than 80 %
improvement in VAS was regarded as excellent
pain relief. Adverse effects, for example
anesthesia dolorosa, moderate headache, facial
numbness, mastication muscle weakness, facial
swelling, nausea and vomiting, CSF leakage,
pain at entry site and facial dysthesia were
recorded.
Statistical analysis
The data were tabulated and analyzed using
Statistical Package of Social Science program,
(SPSS version 20.0) software Qualitative data
were expressed as number and percentage and

 
2

analyzed using The chi square x
test
Quantitative data were expressed as mean ± SD
and analyzed by using the t‑test as P value
>0.05 not statistically significant , P value
<0.05 statistically significant and P value
<0.01 highly statistically significant.
RESULTS
Patients’ demographic data of two studied
groups:
Statistically, there were no significant
differences between the demographic data of
two studied groups (Table 1)
Age was distributed as 55.91±6.29 and
53.35±6.51
between
studied
groups
respectively with no statistically significant
259 | P a g e
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difference between both groups, also there was
no statistically significant difference between
groups regarding to gender as female were
represent about two thirds of both groups,
regarding duration of medical treatment and
duration of intervention
there was no
statistically significant difference between both
groups.
Pain severity before and at different times of
measurements after treatment of the two
studied groups:
Statistically, the baseline (pretreatment) VAS
values of both TRF and PRF groups were
comparable. VAS values of both TRF and PRF
groups at 1st day, 1st week and 1st month after
treatment were comparable with each other but
they highly significant below the corresponding
pretreatment value. The VAS values of TRF
group at 3rd month and at both 6th and 12th
months after treatment were significantly and
highly significant lower than the corresponding
VAS values of PRF and these value of both
groups were highly significant below the
corresponding pretreatment value (Table 2 ) (
Figure 2).

Results of the present study demonstrated that
there was a statistically statistically highly
statistically significant difference as regards
VAS at different stages of follow up after TRF
when
compared
with
pretreatment
stage (Table 3). Moreover, there was a highly
statistically significant difference in VAS
between different stages of follow up after PRF
when
compared
with
pretreatment
stage (Table 3).
The incidence of the various associated side
effects in the two studied groups:
Statistically, the incidence of facial numbness
in TRF group was highly significant higher
than in PRF group . Also the incidence of
anesthesia dolorosa , moderate headach,
mastication muscle weakness and facial
dysthesia, in TRF group were significantly
higher than those in PRF group ( Table 4 ).
The incidence of facial numbness in TRF group
was 33.3% (15 patients) in the 1st day reduced
to 22.3%(10 patients) at first month and
reduced significantly to 6.7% (3 patients) at 3rd
month and to 0.0% at 6th and 12th months
(Figure 3 ).

Table (1): patient characteristics and duration of medical treatment and interventionof the two studied groups
TRF group
n = 45
Data
Gender
Male
Female
Age (years)
X ± SD
Range (ys)
Duration of medical treatment (years)

N

14
31

PRF group
n = 45
%

N

%

P

31.1%
68.9%

16
29

35.6%
64.4%

0.65

55.91±6.29
48.2 - 62.2
2.17±0.88

53.35±6.51
47.84 - 66.9
2.16±0.7

0.062

24±0.59

22±0.79

0.08

0.947

Duration of intervention (min.)

Data are presented by mean standard deviation or number (%)
n= total numberof paients in each group
N= number of femal and male patient in each group
P<0.05 means non significant difference
Age was distributed as 55.91±6.29 and 53.35±6.51 between studied groups respectively with no statistically
significant difference between both groups, also there was no statistically significant difference between groups
regarding to gender as female were represent about two thirds of both groups, regarding duration of medical
treatment and duration of intervention there was no statistically significant difference between both groups.
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Table (2): VAS values in TRF group versus PRF group at different times of measurements
VAS score

pretreatment
1st Day
1st week
1st Month
3rd Month
6th Month

Thermocoagulation
Radiofrequency group
(TRF)
n = 45
8.82±0.77
3.61±0.66
2.29±0.80
1.43±0.65
1.0±0.35*
0.62±0.23**

Pulsed
Radiofrequency group
(PRF)
n = 45
8.88±0.68
3.87±0.58
2.40±0.66
1.52±0.51
1.38±0.34
2.51±0.82

12th Month

0.57±0.16**

3.64±0.91

P

0.666
0.115
0.192
0.289
0.008
˂0.001
˂0.001

* Statistically Significant
** highly statistically significant
There was no significant difference between both groups as regard pretreatment, 1 st day, 1st week, 2nd week, 3rd
week and 1st month after treatment.
Thermocoagulation radiofrequency group was significantly lower VAS score at 3 rd month and was highly
significantly at 6th and 12th months after treatment than pulsed radiofrequency group.

Table (3): Comparison of VAS values at different times of measurments after treatment of the two
studied groups with their corresponding pretreatment VAS value.
Group

VAS score

Mean

Standerd
Deviation

P

Pre treatment

8.82

0.78

˂0.001**

1 day
Pre treatment
1st Month
Pre treatment
3th Month
Pre treatment
6th Month
Pre treatment
12th Month
Pre treatment

2.51
8.82
1.42
8.82
1.04
8.82
0.62
8.82
0.58
8.89

0.66
0.78
0.69
0.78
0.35
0.78
0.23
0.78
0.16
0.68

1st day
Pre treatment
1st Month
Pre treatment
3th Month
Pre treatment
6th Month
Pre treatment
12th Month

2.47
8.89
1.52
8.89
1.38
8.89
2.51
8.89
3.64

0.58
0.68
0.52
0.68
0.52
0.68
0.87
0.685
0.91

PRF
Group
n=45

TRF
Group
n=45

st

˂0.001**
˂0.001**
˂0.001**
˂0.001**
˂0.001**
˂0.001**
˂0.001**
˂0.001**
˂0.001**

n= total number of patients in each group.
P> 0.001 means highly significant differences
Abdalla M., et al
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Table (4): The incidence of various associated side effects in the two studied groups
Complication
TRF
PRF
Group
Group
n = 45
n = 45
N
%
N
%
Anesthesia dolorosa
5*
11.1*
0
0.0
Moderate headache
5*
11.1*
1
2.2
Facial numbness
15**
33.3**
0
0.0
Mastication Muscle weakness
5*
11.1*
0
0.0
Facial swelling
10
22.2
8
17.7
Nausea vomiting
6
13.3
8
17.7
CSF Leakage
2
4.4
1
2.2
Pain at entry site
8
17.7
7
15.5
Facial dysthesia
3*
6.7*
0
0.0

P

0. 01
0.01
˂0.001
0.01
0.42
0.48
0.39
0.72
0.02

* statistically significant
** highly statistically significant
n= total number of patients in each group
N= number of patients with each side effect
P> 0.001 means highly statistically significant
P< 0.05 means non statistically significant

Data were expressed as number and percentage

a

b
Fig( 1 ): a. submental and b. Lateral view of the Foramen Ovale)
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VAS score
10

9

VAS
score

8
7
6
5

TR
F
g…

4
3
2
1

*

0

*

*

Figure (2): VAS at the different times of measurements in the studied groups
VAS score decreased in both groups until 1st month after intervention but VAS score increases in PRF
group and recurrence of pain by the tim in follow up
So TRF group was significantly lower VAS score at 3rd month and was highly significantly at 6th and
12th months after treatment than pulsed radiofrequency group.

% of patients
40.0%
30.0%
20.0%
10.0%
0.0%
1st day

1st month

3rd
months

6th month

12th
month

Figure ( 3 ): Incidence of facial numbness in different times of measurements inTRF group
Facial numbness decreased by the time in TRF group and disappeared from 6th month.
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DISCUSSION
TN is described as the most irritating
pain known to humanity [2]. Various drugs and
surgical procedures have been used for
treatment.
Despite
numerous
available
approaches, the results are not completely
satisfying.[13] The treatment of patients with
refractory TN is often a challenge in clinical
practice. By far, one of the most common
procedures to treat pain is the use of
radiofrequency lessoning (RF). The main
advantages of radiofrequency seem to be its
effectiveness and high pain relief rate [1].
Interventional procedures include glycerol
injection,
percutaneous
balloon
microdecompression, rhizotomy, thermocoagulation
with RF, microvascular decompression, and
gamma knife radiosurgery, they have numerous
advantages including being minimally invasive,
quick and having a low incidence of adverse
events: these advantages are balanced with a
risk of recurrence, which increases over time.all
of which may be necessary when other
treatments fail[14].
The present study revealed that the ratio of
males to females complaining from TN was
1:2, it is closely twice as common in women. A
similar pattern of results was obtained in
previous studies [15] [16] [17].
This can be due to the posterior fossa volume in
males was larger than posterior fossa volume in
females. This finding, along with the higher
incidence of TN in females, suggests that
smaller posterior fossa volume might be an
independent factor in the pathophysiology of
TN [18].
In the present study, a comparison was made
between the TRF and PRF groups in the
treatment of refractory TN. As regards pain
relief, there was a significant improvement in
VAS in both groups throughout the follow‑up
period; follow‑up was scheduled on the first
day, at first month, at 3 months, at 6 months
and at 12 months after treatment. This
improvement continued up to 12 months. PRF
patients showed a higher rate of recurrence of
pain at 3rd month of follow up. It wasstated that
thermocoagulation offers the highest rates of
Abdalla M., et al
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complete pain relief; this is in agreement with
the present study, as we found a highly
significant difference in VAS scores at different
time points of follow‑up compared with
pretreatment results [19].
In agreement with our resultsA similar pattern
of results was obtained that complete pain relief
was found immediately after the procedure in
all patients up to the third month follow‑up;
after that, pain began to return in the PRF group
rather than in the TRF group [20].
In agreement with our results,It was
illustrations that thermocoagulation of the
gasserian ganglion is achieved with a technical
success of 98–100%. [21] Also, Immediate pain
relief is described as high as 90–95% in
multiple studies [20][22][23].
In contrast, it was demonstrated that after TRF
treatment pain relief can be achieved in 98%
patients but 15%–20% of patients may
experience recurrence of pain in 12 months [10]
and It was reported that pain recurrence rates
are between 25% and 60% after TRF with high
incidence of side-effects [24].
It was demonstrated that Pulsed RF is effective
and safe technique for TN patients resistant to
conservative management.[17] with increase
gradually in VAS score with the time in follow
up [25].
Trigeminal neuralgia has been treated by TRF
of gasserian ganglion effectively. However, it
has postoperative side effect such as facial
numbness,
anesthesia
dolorosa,
facial
dysethesia and masseter muscle weakness [26].
Anesthesia dolorosa may also occur following a
trigeminal rhizotomy, it is referred to as a
syndrome
[27]
deafferentation
pain
Complications like anesthesia dolorosa, though
considered rare by some, are regarded to be
worse than the initial pain of TN. It was
perhaps for this reason that PRF was explored
as a less risky alternative [27][28].
In agreement with our observations, The
intensity of facial dysethesia was mildest in the
TRF group on the seventh day after the
procedure and was improved in most cases by
the sixth month [29].
264 | P a g e
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There was a statistically significant difference
in the incidence of facial numbness between
groups I and II. facial numbness can be relieved
over short time as it was observed in 15 patients
in group. The time to recovery from facial
numbness was 4.4±1.9 (3–6) months, by the
end of the 3 months there were only 3 patients
complaining from facial numbness and by end
of 6 month all patients recovery from
numbness; no severe facial numbness occurred.
In agreement with our results, the incidence of
facial numbness was lower in TRF group as
previous studies [30][31]. The lower incidence
might be accounted for by the lower
temperature (60 ◦C) used for TRF in our study.
The incidence of complications after TRF is
directly correlated with the temperature of TRF
[26].
Patients undergoing TRF plus PRF had
decreased recurrence; reduced complications,
including corneal hypoesthesia; and shortened
time to recovery compared with patients
undergoing TRF only. recently reported that
PRF reduced the complications and shortened
the recovery time after TRF [22][31].
It was demonstrated that a combination of TRF
with PRF could help eliminate postoperative
complications of trigeminal neuralgia but not
increase the pain relief [32].
Limitations of the present study: few
number of cases of trigeminal neuralgia
CONCLUSION
Under the condition of the present study we can
conclude thermocoagulation radiofrequency is
more effective than in pulsed radiofrequency in
relieving pain associated with refractory
trigeminal neuralgia but associated with more
side effects.
RECOMMENDATION
Larger scale, prospective work encompassing
combined TRF and PRF, separate PRF and
separate TRF groups may yield more solid and
clear data.
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